Results of Clinical Examinations, Laboratory Tests, and Ultrasonography in Dogs with Pituitary-Dependent Hyperadrenocorticism Treated with Trilostane
April 2002
in “
American journal of veterinary research
”
trilostane 3β-hydroxysteroid dehydrogenase inhibitor pituitary-dependent hyperadrenocorticism PDH ACTH stimulation tests cortisol adrenal glands polyuria-polydipsia panting polyphagia coat quality skin condition trilostane ACTH tests cortisol adrenal glands increased thirst and urination panting increased appetite coat quality skin condition
Studysummary This study found trilostane to be an effective and generally safe treatment for improving symptoms in dogs with pituitary-dependent hyperadrenocorticism.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on avmajournals.avma.org →